Novel classification methods for pleural effusions

• US 20040086864A1
• Filed: 10/22/2002
• Published: 05/06/2004
• Est. Priority Date: 10/22/2002
• Status: Abandoned Application

• Current Assignee: Chinese University of Hong Kong
• Original Assignee: Chinese University of Hong Kong
• Inventors: Chan, Michael Ho-Ming, Lo, Yuk Ming Dennis
• Application Number:
  US10/278,278
• Publication Number:
  US 20040086864A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12Q 1/6883 for diseases caused by alterations of genetic material
• CPC Class Codes: C12Q 2600/112 Disease subtyping, staging or classification
• CPC Class Codes: C12Q 2600/158 Expression markers

Abstract

This invention relates to the detection of nucleic acids in the pleural fluids of a patient suffering from a pleural effusion for the classification of the pleural effusion.

Claims

1. A method of classifying a pleural effusion in a subject as transudative or exudative, the method comprising:

(i) obtaining a sample of pleural fluids from a patient suffering from a pleural effusion, and

(ii) detecting the concentration of human nucleic acid in the sample, with the proviso that the nucleic acid is not overexpressed in cancer cells and is not telomerase or adenosine deaminase nucleic acid, and

(iii) classifying the pleural effusion as transudative or exudative by comparing the concentration of nucleic acid in the sample to a standard.

2. The method of claim 1, wherein the exudative effusion is further classified as a malignant effusion or an infective effusion.

3. The method of claim 1, wherein the patient is suffering from a disease selected from the group consisting of congestive heart failure, end-stage renal failure, pulmonary tuberculosis, empyema, chest infection, malignant neoplasm, pulmonary embolism, pneumonia, liver disease, kidney disease, and lymphangitis carcinomatosis.

4. The method of claim 1, wherein the nucleic acid in the sample is DNA.

5. The method of claim 1, wherein the nucleic acid in the sample is RNA.

6. The method of claim 4, wherein the DNA is the β

-globin gene DNA.

7. The method of claim 1, further comprising the step of amplifying the nucleic acid.

8. The method of claim 7, wherein the nucleic acid is DNA and the DNA is amplified using PCR.

9. The method of claim 8, wherein the DNA is amplified using real-time PCR.

10. The method of claim 7, wherein the nucleic acid is RNA and the RNA is amplified using reverse transcriptase PCR.

11. The method of claim 10, wherein the RNA is amplified using reverse transcriptase real-time PCR.